A notable surge in bearish bets is placing short sellers of Coinbase under the microscope. As Bitcoin’s price vaults past the $72,000 level, data from S3 Partners indicates the short interest in the crypto exchange has doubled from approximately 5% in December to around 10% currently. This activity has pushed the firm’s “Crowded Shorts” score to a new company high of 50 out of 100, while a separate Short-Squeeze Score sits at a elevated 82 out of 100, signaling heightened risk for those betting against the stock.
A High-Risk, High-Beta Proposition
Market researchers characterize Coinbase as a “high-beta risk asset,” noting its price correlation of 0.60 with Bitcoin and 0.52 with the S&P 500. This strong linkage explains why the company’s shares have mirrored the broader technology sector sell-off in recent weeks, a trend fueled by climbing oil prices above $100 per barrel and renewed inflation concerns.
However, Leon Gross, Research Director at S3, urges caution in interpreting the squeeze metrics. He points out that last year, the score exceeded the 70 threshold on three separate occasions without triggering an actual short squeeze. The elevated figure, therefore, represents a risk indicator rather than a guaranteed catalyst.
Regulatory Tailwinds and Strategic Shifts
The investment case for Coinbase is a tale of contrasting forces. On one hand, the stock has declined roughly 15% year-to-date, pressured by a missed Q4 2025 earnings target, weaker retail trading volumes, and a 35% jump in full-year 2025 operating expenses to $5.7 billion.
Should investors sell immediately? Or is it worth buying Coinbase?
Conversely, the regulatory landscape has improved significantly. The Securities and Exchange Commission (SEC) dropped its case against the company in early 2025, and Congress passed the GENIUS Act, establishing the first federal regulatory framework for stablecoins. A major catalyst occurred when it was revealed that U.S. President Donald Trump met personally with CEO Brian Armstrong and publicly backed the firm in a crypto legislative dispute, sending shares soaring 15.2% in a single trading session.
Strategically, Coinbase is actively diversifying its platform. The company introduced commission-free stock and ETF trading for U.S. customers in late February and launched a partnership with prediction market provider Kalshi in January. It now boasts 12 distinct products each generating over $100 million in annualized revenue.
Divergent Analyst Views and Early Q1 Signals
Wall Street analysts remain divided on the stock’s outlook. Following the Q4 earnings miss, Canaccord Genuity reduced its price target from $400 to $300 but maintained a Buy rating. UBS holds a $264 target. Barclays analyst Benjamin Budish presents a more skeptical view, maintaining an “Equal Weight” rating and a $148 price target, having already cut it from $258 in February.
Early data for the first quarter of 2026 hints at a potential rebound. Transaction revenue reached approximately $420 million by February 10th, a figure achieved with only about half the quarter elapsed. Whether this momentum is sufficient to address profitability concerns will become clearer with the Q1 results—a report that will undoubtedly be scrutinized closely given the record level of short interest.
Ad
Coinbase Stock: Buy or Sell?! New Coinbase Analysis from March 15 delivers the answer:
The latest Coinbase figures speak for themselves: Urgent action needed for Coinbase investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 15.
Coinbase: Buy or sell? Read more here...
